Mirae Asset Global ETFs Holdings’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$888K Buy
94,461
+6,619
+8% +$59.3K ﹤0.01% 1697
2026
Q1
$714K Sell
87,842
-892
-1% -$8.09K ﹤0.01% 1692
2025
Q4
$596K Buy
88,734
+5,958
+7% +$44.9K ﹤0.01% 1797
2025
Q3
$716K Sell
82,776
-11,830
-13% -$92.1K ﹤0.01% 1681
2025
Q2
$597K Sell
94,606
-9,956
-10% -$65.9K ﹤0.01% 1724
2025
Q1
$678K Buy
104,562
+2,750
+3% +$22.7K ﹤0.01% 1697
2024
Q4
$817K Buy
101,812
+9,711
+11% +$93.6K ﹤0.01% 1657
2024
Q3
$1.17M Buy
92,101
+25,297
+38% +$327K ﹤0.01% 1448
2024
Q2
$847K Buy
+66,804
New +$672K ﹤0.01% 1547

Other funds holding NVAX

Mirae Asset Global ETFs Holdings's NVAX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Novavax (NVAX) stake by 7.5% in Q2 2026, buying an estimated $59.3K and bringing the position to 94,461 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

Mirae Asset Global ETFs Holdings first reported a position in NVAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.17M in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 94,461 shares of Novavax worth $888K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 6,619 Novavax shares in Q2 2026, an estimated $59.3K.
  • Novavax made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1697 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Novavax in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Novavax position peaked at $1.17M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.